Abstract
Objective
To explore traditional herbal medicines as potential risk factors of severe preeclampsia and eclampsia in Nigeria.
Methods
We conducted a retrospective case-control study from October 2010 to May 2011. The cases were all pregnant women admitted to the Jahun Hospital during the study period with severe preeclampsia or eclampsia and women presenting with normal pregnancy after 22 weeks.
Results
During the study period, a total of 1,257 women (44%) were recorded as having normal pregnancy, and 419 (16%) women had severe preeclampsia/eclampsia (175 with severe preeclampsia and 244 with eclampsia). The risk factors found to be associated with a greater risk of severe preeclampsia/eclampsia included personal history of preeclampsia (odds ratio [OR] = 21.5; P < 0.001), personal history of preexisting hypertension (OR = 10.5; P < 0.001), primiparity (OR = 2.5; P = 0.001), occupation as housewife (OR = 1.9; P = 0.008), and fewer than four antenatal care visits (OR = 1.6; P = 0.02). Use of traditional treatments during pregnancy was associated with a higher risk of developing severe preeclampsia/eclampsia (OR = 1.6 95%; confidence interval [CI]: 1.2–2.1) by univariate analysis only.
Conclusion
Use of traditional treatment, which increases delays before consulting the official health sector, might be a marker for harmful behavior. Community-based studies could provide additional information on the practice of herbal therapy in this population.
Introduction
Most of maternal deaths are due to obstetric emergencies, including hemorrhage, sepsis, obstructed labor, and hypertensive disorders,Citation1,Citation2 with eclampsia being the leading cause of maternal and perinatal mortality reported in Nigeria over the last decade.Citation3 In addition, preeclampsia and eclampsia are major causes of fetal mortality.Citation4 The etiology of preeclampsia remains unclear despite extensive research.
It is noteworthy that the use of herbal medicines is widespread among pregnant women in Nigeria,57 where the legislation for distribution and purchase of herbal remedies is not as stringent as it is for conventional medicines. In this country, the prevalence of herbal remedy use during pregnancy ranges from 12%Citation7 to 67%.Citation5 The reasons cited by pregnant women for taking herbal medicines include perceived higher efficacy, easier access and lower cost compared with conventional medicines, safety in pregnancy, and beliefs concerning the cultural heritage of herbal remedies.Citation5 However, side effects and the teratogenic potential of most herbal products are poorly understood. A recent study performed in Nigeria found a strong association between self-medication, including herbal use, and hypertension in pregnancy.Citation8
An emergency obstetric and neonatal care program, operated by Médecins Sans Frontières, has been operating in Jahun, a town in the Jahun Local Government Area in Jigawa State, Nigeria, as part of a comprehensive obstetric package since July 2008. The catchment area that the Jahun hospital serves is 380,000 persons (combining the Jahun and Miga Local Government Areas). The main objective of the program is to decrease maternal and neonatal mortality among those presenting at the Jahun hospital, by addressing the health seeking behavior of women with complications during pregnancy and delivery, the access to health structures, and the quality of care provided at the emergency obstetric and neonatal care program. The current capacity of the hospital is a 41-bed ward (35 standard beds and six intensive care unit beds), staffed with seven midwives (trained to manage labor and delivery and to assist newborns) and four nurse assistants (trained to assist mothers and help midwives) per shift. A recently created neonatal care unit includes resuscitation. A recent analysis of the activity showed that more than 70% of admissions were complicated deliveries, with a seasonal trend of admissions (217 in January and 413 in August). A surprisingly high number of patients with hypertension as a complication of pregnancy were noted, several of whom were diagnosed with preeclampsia or eclampsia (4% of patients presented with eclampsia compared with the 1% of eclamptic disorder predicted according to the World Health Organization [WHO] standards).Citation9 Typically, the presentation was that of pregnant women after 20 weeks gestational age, arriving in the maternity unit with a history of “Jijjiga,” which is the local language (Hausa) term for seizures. This study was undertaken to describe the characteristics and outcome of the population affected by severe pregnancy-related hypertensive disorders in the Jahun maternity ward and to identify potential risk factors for severe preeclampsia and eclampsia, including use of traditional treatment.
Subjects/materials and methods
Design
In order to identify potential risk factors for severe preeclampsia/eclampsia among women in the Jahun region, we conducted a hospital-based case-control study over a 7-month period. The cases and controls were selected from the emergency obstetric program operating in the rural hospital of Jahun. All pregnant women admitted to the Jahun hospital from October 2010 to May 2011 were prospectively included in this study. Local team members interviewed patients and family members using a structured questionnaire requesting information about general demographic characteristics (maternal age, ethnicity, home village, and occupation), body mass index, blood group and Rhesus factor, hemoglobin disease, past medical history (parity, age at menarche, history of preeclampsia, pregestational hypertension/diabetes, family history of hypertension/preeclampsia), social history (literacy level, level of education, household details, baby’s father’s occupation), present history (current gestation details, clinical examination, available biological tests), use of traditional treatments, delivery details and neonatal outcome. Patients who visited the Jahun maternity ward and were diagnosed with severe preeclampsia and/or eclampsia during the study period were identified as cases. During the same period, women with normal pregnancy attending the Jahun maternity ward were identified as controls. For the purposes of the study, traditional treatments included herbal medicines either obtained from the wild in the crude form or as refined forms, such as concentrated extracts, teas, tinctures, or decoctions. Among others, the herbal medicines used during pregnancy in the study community included “saiwan goruba,” to treat bleeding; “chediya,” “taura,” and “sabara,” to ease abdominal pain; and “meleduwa,” administered for rupture of the amniotic sac (the herbs are named after their local names).
Definition of preeclampsia and eclampsia
Eclampsia was defined as occurrence of seizure and/or altered level of consciousness not caused by epilepsy or other convulsive disorders, with signs of severe preeclampsia. Severe preeclampsia was defined as new hypertension with blood pressure of 160 mmHg systolic or diastolic blood pressure of 110 mmHg, or greater, arising after 20 weeks of gestation in a woman who was normotensive before 20 weeks gestation, associated with proteinuria. Proteinuria was defined as a finding of 2+ or more protein on urine dipstick. Women with 1+ protein on urine dipstick were excluded in order to limit misclassification bias.
Definition of neonatal death
Neonatal death was defined as “a disease or injury which initiated the train of morbid events leading directly to death” within the first 28 days of life. The primary causes of neonatal death were broadly grouped under four major headings: (1) birth asphyxia, (2) sepsis (pneumonia, septicemia, and meningitis), (3) prematurity, and (4) other.
Data were analyzed using STATA Statistical Software: Release 11 (StataCorp LP College Station, TX, USA). The median and range were used for quantitative variables that were not normally distributed, and mean and 95% confidence intervals (CI) were used for normally distributed variables. Categorical variables were tabulated using frequencies and percentages. The Chi-square test was used for testing the significance of associations between categorical variables. Group differences were tested using the unpaired Student’s t-test in cases of normal distribution and the nonparametric Mann–Whitney U-test in cases of skewed distribution. Crude and adjusted odds ratios (OR) and 95% CI were calculated. Multiple logistic regression models were constructed to identify independent factors associated with severe preeclampsia/eclampsia. Initial regression models were first constructed including all variables for which (1) the P-value (for the OR) was less than 0.05, and (2) the OR was more than 1.1 or less than 0.90 in the univariate analysis. If two or more factors were highly correlated, only the most plausible one (from the literature) or the one with the fewest missing values was included in the model. To simplify the model, variables were removed one at a time depending on the significance test (P < 0.05) by the likelihood ratio test.
Results
During the study period, a total of 2,835 pregnant women were admitted to the Jahun hospital. Among them, 1,257 (44%) were recorded as having a normal pregnancy, and 419 (16%) women had severe preeclampsia/eclampsia (175 with severe preeclampsia and 244 with eclampsia). Among the eclamptic patients, 194 were antepartum and intrapartum, and 50 were admitted with postpartum eclampsia after a vaginal delivery at home. The sociodemographic, obstetric, and antenatal characteristics of all participants are shown in . No significant differences were observed between cases and controls with regard to geographical area of origin or referral health centre, source of admission, time to reach hospital, or ethnicity. The cases were younger (mean age 21 years; 95% CI: 21–23) than the controls (mean age 25 years; 95% CI: 24–26) (P < 0.001). The mean gestational age at delivery was not significantly different between the two groups. The proportion of cases (79%) with fewer than four antenatal clinic visits was significantly higher than controls (73%), by univariate analysis only. Eleven percent of eclamptic patients experienced no signs of severe hypertension, such as headache or visual changes.
Table 1 General characteristics of cases and controls admitted to the Jahun hospital maternity ward, October 2010–May 2011
A majority of women delivered at the Médecins Sans Frontières [Doctors Without Borders] hospital (75%) and used traditional treatments during their pregnancy (63%). The proportion of cesarean sections was significantly higher among cases (7%) than in controls (0%). The mean hospital length of stay was significantly longer among cases (4 days) compared with controls (1 day) (P < 0.001). Out of 419 cases, ten patients died (mortality of 2.4%). One death only was attributable to eclampsia.
The stillbirth rate was significantly higher among cases (11%) compared with controls (7%) (P = 0.001). The neonatal outcome was similar in both groups. shows the delivery characteristics and outcome details of the cases and controls.
Table 2 Delivery and outcome of cases and controls at the Jahun hospital maternity ward, October 2010–May 2011
Referring to , the significant variables included in the final model were age, school attendance, occupation, parity, number of household members, personal history of preeclampsia/eclampsia or hypertension, family history of preeclampsia/eclampsia or hypertension, number of antenatal clinic visits, and use of traditional treatment during pregnancy.
Table 3 Factors associated with severe preeclampsia and eclampsia in patients admitted at the Jahun hospital maternity ward, unadjusted and adjusted for potential confounding factors
After adjusting for the effect of the other variables in the model, the risk factors found to be associated with a greater risk of severe preeclampsia/eclampsia included personal history of preeclampsia (OR = 21.5; P < 0.001), personal history of preexisting hypertension (OR = 10.5; P < 0.001), primiparity (OR = 2.5; P = 0.001), occupation as a housewife (OR = 1.9; P = 0.008) and fewer than four antenatal clinic visits (OR = 1.6; P = 0.02). The use of traditional treatments during pregnancy was associated with a higher risk of developing severe preeclampsia/eclampsia (OR = 1.6; 95% CI: 1.2–2.1), by univariate analysis only. Similarly, the protective effect of older maternal age, higher number of household members, and school attendance disappeared in the multivariate analysis.
Discussion
The results of this study are consistent with the usual risk factors for severe pregnancy-related hypertensive disorders, including primiparity and personal history of hypertensive disorders. As expected, low socioeducational status (assessed by school attendance and patient’s occupation) appears to be strongly associated with preeclampsia/eclampsia.
Interestingly, the proportion of eclampsia was greater than the proportion of severe preeclampsia. Although time to referral and delay in hospitalization were not measured, it is very likely that those parameters would have been identified as risk factors for developing eclampsia. About one-half of the patients admitted to the hospital for eclampsia had antepartum preeclampsia, similar to what has been reported in other studies carried out in Nigeria.Citation10–Citation13 While it is clear that good antenatal care will reduce the incidence of eclampsia, it has been reported that less than 20% of eclamptic cases were preventable, in studies performed in the USACitation14 and in Sweden.Citation15
Usage of traditional herbal treatments before or during the pregnancy was not found to be associated with developing severe preeclampsia/eclampsia. Herbal drug preparations were found to be very popular among the women included in this study, as is usually the case in other parts of Nigeria.Citation5–Citation7 Although the reasons for use were not formally recorded, reduction of nausea and vomiting associated with early pregnancy was repeatedly mentioned. Additionally, cure of specific symptoms, such as abdominal pain, jaundice, or edema were noted. Although these herbal drugs are readily available and cheap, there is a lack of specific dose and lack of information about their side effects and their safety during pregnancy. Without pharmacological data, we cannot exclude toxicity from the traditional medicines used in the study population. Hence, our reassuring finding regarding the absence of association between eclampsia and traditional treatments needs to be confirmed. It is also possible that use of traditional medicines, which increases the delay before consulting a health center, is simply a marker for harmful behavior.
Limitations
This study has several limitations. First, the hospital-based approach includes only women attending the hospital; as many women and neonates die in rural Africa without presenting to a health structure, community-based studies are a better instrument for exploring mortality rates. Second, the use of traditional medicine might be associated with a more severe disease, and the (pre)eclampsia may only be the outcome of evaluating a certain group of patients. Matched pairs of women of the same age and diagnosis would provide a better study design to answer this question. Third, we did not investigate in detail the practice of herbal therapy in the study population. Once again, a community-based study would better assess traditional practices involving practitioners and herbalists. Finally, the study period was not long enough to record any seasonal trend in hypertensive disorders.
Conclusion
The rate of severe pregnancy-related hypertensive disorders in the Jahun maternity ward is very high and consistent with the findings of other studies in Northern Nigeria. The proportion of eclampsia was higher than the proportion of preeclampsia, suggesting that reducing delay of presentation might be highly beneficial. No specific risk factors for severe preeclampsia and eclampsia were identified other than the usual indicators for those disorders; a community-based study would allow us to better detail the practice of herbal therapy in this population. Perinatal death rate remains high in preeclamptic/eclamptic women.
Acknowledgments
We greatly acknowledge the Médecins Sans Frontières staff and all the dedicated Nigerian field workers and translators who assisted with this project.
Disclosure
The authors declare that they have no conflicts of interest in this work.
References
- OlatunjiAOSule-OduAOMaternal mortality at Sagamu, Nigeria – a ten year review (1988–1997)Niger Postgrad Med J200181121511487777
- OkaroJMUmezulikeACOnahHEChukwualiLIEzugwuOFNwekePCMaternal mortality at the University of Nigeria Teaching Hospital, Enugu, before and after KenyaAfr J Reprod Health200152909712471917
- OkusanyaBOAigereEOAbeAIbrahimHMSalawuRAMaternal deaths: initial report of an on-going monitoring of maternal deaths at the Federal Medical Centre Katsina, Northwest NigeriaJ Matern Fetal Neonatal Med201326988588823311885
- WeindlingAMThe confidential enquiry into maternal and child health (CEMACH)Arch Dis Child200388121034103714670760
- FakeyeTOAdisaRMusaIEAttitude and use of herbal medicines among pregnant women in NigeriaBMC Complement Altern Med200995320043858
- OlogeMOAboyejiAPIjaiyaMAAdesinaKTAdewaraAAOlarinoyeJKHerbal use among pregnant mothers in Ilorin, Kwra State, NigeriaJ Obstet Gynaecol200828772072119065368
- GharoroEPIgbafeAAPattern of drug use amongst antenatal patients in Benin City, NigeriaMed Sci Monit200061848711208289
- BelloFAMorhason-BelloIOOlayemiOAdekunleAOPatterns and predictors of self-medication amongst antenatal clients in Ibadan, NigeriaNiger Med J201152315315722083501
- World Health OrganizationWHO recommendations for prevention and treatment of pre-eclampsia and eclampsia2011 Available from: http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdfAccessed July 20, 2013
- OnwuhafuaPIOnwuhafuaAAdzeJMairamiZEclampsia in Kaduna State of Nigeria – a proposal for a better outcomeNiger J Med2001102818411705065
- IkechebeluJIOkoliCCReview of eclampsia at the Nnamdi Azikiwe University teaching hospital, Nnewi (January 1996–December 2000)J Obstet Gynaecol200222328729012521501
- El-NafatyAUMelahGSMassaAAAuduBMNeldaMThe analysis of eclamptic morbidity and mortality in the Specialist Hospital Gombe, NigeriaJ Obstet Gynaecol200424214214714766449
- OkaforUVEfetieRECritical care management of eclamptics: challenges in an African settingTrop Doct2008381111318302851
- KatzVLFarmerRKullerJAPreeclampsia into eclampsia: toward a new paradigmAm J Obstet Gynecol200018261389139610871454
- RugarnOCarling MoenSBergGEclampsia at a tertiary hospital 1973–1999Acta Obstet Gynecol Scand200483324024514995918